[1]
Dey, D.; Debnath, S.; Hazra, S.; Ghosh, S.; Ray, R.; Hazra, B. Pomegranate pericarp extract enhances the antibacterial activity of ciprofloxacin against extended-spectrum β-lactamase (ESBL) and metallo-β-lactamase (MBL) producing Gram-negative bacilli. Food Chem. Toxicol., 2012, 50, 4302-4309.
[2]
Jurenka, J. Therapeutic applications of pomegranate (Punica granatum L.): A review. Altern. Med. Rev., 2008, 13, 128-144.
[3]
Naz, S.; Siddiqi, R.; Ahmad, S.; Rasool, S.; Sayeed, S. Antibacterial activity directed isolation of compounds from Punica granatum. J. Food Sci., 2007, 72(9), M341-M345.
[4]
AlMatar, M.; Islam, M.; Albari, O.; Var, I.; Köksal, F. Pomegranate as a possible treatment in reducing risk of developing wound healing, obesity, neurodegenerative disorders, and diabetes mellitus. Mini Rev. Med. Chem., 2018, 18(6), 507-526.
[5]
Viuda-Martos, M.; Fernández-López, J.; Pérez-Álvarez, J. Pomegranate and its many functional components as related to human health: A review. Compr. Rev. Food Sci. Food Saf., 2010, 9, 635-654.
[6]
Cowan, M.M. Plant products as antimicrobial agents. Clin. Microbiol. Rev., 1999, 12, 564-582.
[7]
Lansky, E.P.; Newman, R.A. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J. Ethnopharmacol., 2007, 109, 177-206.
[8]
Braga, L.; Shupp, J.; Cummings, C.; Jett, M.; Takahashi, J.; Carmo, L.; Chartone-Souza, E.; Nascimento, A. Pomegranate extract inhibits Staphylococcus aureus growth and subsequent enterotoxin production. J. Ethnopharmacol., 2005, 96, 335-339.
[9]
Al-Zoreky, N. Antimicrobial activity of pomegranate (Punica granatum L.) fruit peels. Int. J. Food Microbiol., 2009, 134, 244-248.
[10]
Opara, L.U.; Al-Ani, M.R.; Al-Shuaibi, Y.S. Physico-chemical properties, vitamin C content, and antimicrobial properties of pomegranate fruit (Punica granatum L.). Food Bioprocess Technol., 2009, 2, 315-321.
[11]
Aviram, M.; Volkova, N.; Coleman, R.; Dreher, M.; Reddy, M.K.; Ferreira, D.; Rosenblat, M. Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: Studies in vivo in atherosclerotic apolipoprotein E-deficient (E0) mice and in vitro in cultured macrophages and lipoproteins. J. Agric. Food Chem., 2008, 56, 1148-1157.
[12]
Shukla, M.; Gupta, K.; Rasheed, Z.; Khan, K.A.; Haqqi, T.M. Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis. Nutrition, 2008, 24, 733-743.
[13]
Obeid, K.M.; Saravolatz, L. Tuberculosis: A comprehensive clinical reference. JAMA, 2009, 302, 2488-2489.
[14]
AlMatar, M.; Makky, E.A.; Var, I.; Kayar, B.; Köksal, F. Novel compounds targeting InhA for TB therapy. Pharmacol. Rep., 2018, 70(2), 217-226.
[15]
Raviglione, M.; Marais, B.; Floyd, K.; Lönnroth, K.; Getahun, H.; Migliori, G.B.; Harries, A.D.; Nunn, P.; Lienhardt, C.; Graham, S. Scaling up interventions to achieve global tuberculosis control: Progress and new developments. Lancet, 2012, 379, 1902-1913.
[16]
Dye, C.; Scheele, S.; Dolin, P.; Pathania, V.; Raviglione, M. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by in an urban community. Int. J. Tuberc. Lung Dis., 2005, 9, 970-976.
[17]
Diel, R.; Loddenkemper, R.; Zellweger, J.; Sotgiu, G.; D’Ambrosio, L.; Centis, R.; van der Werf, M.; Dara, M.; Detjen, A.; Gondrie, P. Reichman, L.; Blasi, F.; Migliori, G.B.; European Forum for TB Innovation. Old ideas to innovate TB control: Preventive treatment to achieve elimination. Eur. Respir. J., 2013, 42(3), 785-801.
[18]
Zumla, A.; Nahid, P.; Cole, S.T. Advances in the development of new tuberculosis drugs and treatment regimens. Nat. Rev. Drug Discov., 2013, 12, 388-404.
[19]
Adami, A.G.; Gallo, J.F.; Pinhata, J.M.W.; Martins, M.C.; Giampaglia, C.M.S.; de Oliveira, R.S. Modified protocol for drug susceptibility testing of MGIT cultures of Mycobacterium tuberculosis by the MGIT 960. Diagn. Microbiol. Infect. Dis., 2017, 87, 108-111.
[20]
Fawole, O.A.; Opara, U.L.; Theron, K.I. Chemical and phytochemical properties and antioxidant activities of three pomegranate cultivars grown in South Africa. Food Bioprocess Technol., 2012, 5, 2934-2940.
[21]
Fischer, U.A.; Carle, R.; Kammerer, D.R. Identification and quantification of phenolic compounds from pomegranate (Punica granatum L.) peel, mesocarp, aril and differently produced juices by HPLC-DAD-ESI/MSn. Food Chem., 2011, 127, 807-821.
[22]
Zhishen, J.; Mengcheng, T.; Jianming, W. The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chem., 1999, 64, 555-559.
[23]
Ozgen, M.; Durgaç, C.; Serçe, S.; Kaya, C. Chemical and antioxidant properties of pomegranate cultivars grown in the Mediterranean region of Turkey. Food Chem., 2008, 111, 703-706.
[24]
Gil, M.I.; Tomás-Barberán, F.A.; Hess-Pierce, B.; Holcroft, D.M.; Kader, A.A. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J. Agric. Food Chem., 2000, 48, 4581-4589.
[25]
Brand-Williams, W.; Cuvelier, M-E.; Berset, C. Use of a free radical method to evaluate antioxidant activity. LWT-Food Sci Technol., 1995, 28, 25-30.
[26]
Nathanson, E.; Nunn, P.; Uplekar, M.; Floyd, K.; Jaramillo, E.; Lönnroth, K.; Weil, D.; Raviglione, M. MDR tuberculosis-critical steps for prevention and control. New. Engl. J. Med., 2010, 363, 1050-1058.
[28]
Kolyva, A.S.; Karakousis, P.C. Old and new TB drugs: Mechanisms of action and resistance.Understanding Tuberculosis-New Approaches to Fighting Against Drug Resistance; InTech, 2012.
[29]
Heifets, L. Susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. J. Med. Microbiol., 2002, 51(1), 11-12.
[30]
Vandal, O.H.; Nathan, C.F.; Ehrt, S. Acid resistance in Mycobacterium tuberculosis. J. Bacteriol., 2009, 191, 4714-4721.
[31]
Dickinson, J.M.; Aber, V.; Mitchison, D. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium tuberculosis. Am. Rev. Respir. Dis., 1977, 116, 627-635.
[32]
Almeida, D.; Nuermberger, E.; Tasneen, R.; Rosenthal, I.; Tyagi, S.; Williams, K.; Peloquin, C.; Grosset, J. Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis. Antimicrob. Agents Chemother., 2009, 53, 4178-4184.
[33]
Grosset, J.; Truffot-Pernot, C.; Lacroix, C.; Ji, B. Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice. Antimicrob. Agents Chemother., 1992, 36, 548-551.
[34]
Drusano, G.; Sgambati, N.; Eichas, A.; Brown, D.L.; Kulawy, R.; Louie, A. The combination of rifampin plus moxifloxacin is synergistic for suppression of resistance but antagonistic for cell kill of Mycobacterium tuberculosis as determined in a hollow-fiber infection model. MBio, 2010, 1, e00139-e10.
[35]
Greco, W.R.; Park, H.S.; Rustum, Y.M. Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-β-D-arabinofuranosyl-cytosine. Cancer Res., 1990, 50, 5318-5327.
[36]
Drusano, G.L.; Neely, M.; Van Guilder, M.; Schumitzky, A.; Brown, D.; Fikes, S.; Peloquin, C.; Louie, A. Analysis of combination drug therapy to develop regimens with shortened duration of treatment for tuberculosis. PLoS One, 2014, 9, e101311.
[37]
Piccaro, G.; Giannoni, F.; Filippini, P.; Mustazzolu, A.; Fattorini, L. Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditions. Antimicrob. Agents Chemother., 2013, 57, 1428-1433.
[38]
Sacchettini, J.C.; Rubin, E.J.; Freundlich, J.S. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis. Nat. Rev. Microbiol., 2008, 6(1), 41-52.
[39]
Mitchison, D.; Fourie, P. The near future: Improving the activity of rifamycins and pyrazinamide. Tuberculosis, 2010, 90, 177-181.
[40]
Zhang, Y.; Mitchison, D. The curious characteristics of pyrazinamide: A review. Int. J. Tuberc. Lung Dis., 2003, 7, 6-21.
[41]
Betanzos-Cabrera, G.; Montes-Rubio, P.Y.; Fabela-Illescas, H.E.; Belefant-Miller, H.; Cancino-Diaz, J.C. Antibacterial activity of fresh pomegranate juice against clinical strains of Staphylococcus epidermidis. Food Nutr. Res., 2015, 59, 27620.
[42]
Ferrazzano, G.F.; Scioscia, E.; Sateriale, D.; Pastore, G.; Colicchio, R.; Pagliuca, C.; Cantile, T.; Alcidi, B.; Coda, M.; Ingenito, A. In vitro antibacterial activity of pomegranate juice and peel extracts on cariogenic bacteria. BioMed Res. Int., 2017, 2017, 2152749.
[43]
Cristani, M.; D’Arrigo, M.; Mandalari, G.; Castelli, F.; Sarpietro, M.G.; Micieli, D.; Venuti, V.; Bisignano, G.; Saija, A.; Trombetta, D. Interaction of four monoterpenes contained in essential oils with model membranes: Implications for their antibacterial activity. J. Agric. Food Chem., 2007, 55, 6300-6308.
[44]
Seeram, N.P.; Aviram, M.; Zhang, Y.; Henning, S.M.; Feng, L.; Dreher, M.; Heber, D. Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States. J. Agric. Food Chem., 2008, 56, 1415-1422.
[45]
Ahn, Y.J.; Lee, C.O.; Kweon, J.H.; Ahn, J.W.; Park, J.H. Growth-inhibitory effects of Galla Rhois-derived tannins on intestinal bacteria. J. Appl. Microbiol., 1998, 84, 439-443.
[46]
Hmid, I.; Elothmani, D.; Hanine, H.; Oukabli, A.; Mehinagic, E. Comparative study of phenolic compounds and their antioxidant attributes of eighteen pomegranate (Punica granatum L.) cultivars grown in Morocco. Arab. J. Chem., 2017, 10, S2675-S2684.
[47]
Artik, N. Determination of phenolic compounds in pomegranate juice by using HPLC. Fruit Process., 1998, 8, 492-499.
[48]
Kosuru, R.Y.; Roy, A.; Das, S.K.; Bera, S. Gallic Acid and gallates in human health and disease: Do mitochondria hold the key to success? Mol. Nutr. Food Res., 2018, 62, 1700699.
[49]
Akhavan, H.; Barzegar, M.; Weidlich, H.; Zimmermann, B.F. Phenolic compounds and antioxidant activity of juices from ten Iranian pomegranate cultivars depend on extraction. J. Chem., 2015, 2015, Article ID 907101, 7.
[50]
Gómez-Caravaca, A.M.; Verardo, V.; Toselli, M.; Segura-Carretero, A.; Fernández-Gutiérrez, A.; Caboni, M.F. Determination of the major phenolic compounds in pomegranate juices by HPLC-DAD-ESI-MS. J. Agric. Food Chem., 2013, 61, 5328-5337.
[51]
Guo, C.; Wei, J.; Yang, J.; Xu, J.; Pang, W.; Jiang, Y. Pomegranate juice is potentially better than apple juice in improving antioxidant function in elderly subjects. Nutr. Res., 2008, 28, 72-77.
[52]
Hasnaoui, N.; Jbir, R.; Mars, M.; Trifi, M.; Kamal-Eldin, A.; Melgarejo, P.; Hernandez, F. Organic acids, sugars, and anthocyanins contents in juices of Tunisian pomegranate fruits. Int. J. Food Prop., 2011, 14, 741-757.
[53]
Çam, M.; Hışıl, Y.; Durmaz, G. Classification of eight pomegranate juices based on antioxidant capacity measured by four methods. Food Chem., 2009, 112, 721-726.
27
3
1